id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-N-0719-0006,FDA,FDA-2013-N-0719,"Agency Information Collection Activities; Announcement of Office of
Management and Budget Approvals",Notice,Notice of Approval,2017-07-03T04:00:00Z,2017,7,2017-07-03T04:00:00Z,,2017-07-03T15:54:12Z,2017-13890,0,0,09000064827dee90
FDA-2013-N-0719-0004,FDA,FDA-2013-N-0719,"Agency Information Collection Activities; Submission for Office of
Management and Budget Review; Comment Request; Guidance for
Industry on Planning for the Effects of High Absenteeism To Ensure
Availability of Medically Necessary Drug Products",Notice,30 Day Proposed Information Collection,2017-03-15T04:00:00Z,2017,3,2017-03-15T04:00:00Z,2017-04-15T03:59:59Z,2017-03-16T01:02:31Z,2017-05100,0,0,0900006482508929